Anti-Microbial Solutions, LLC looks fair against its niche peers and is dormant on financing cadence.
Raised $4.5M across 5 disclosed rounds, last modeled as Seed (a $1.0M–$4.0M round).
Modeled value is 0.80× the median modeled value of Seed Other Technology companies in 2007–2009 (266 peers) — value vs value, same stage and era.
Valued on the technology profile — its sector's growth and survival benchmarks differ from the market default, so the same raise is worth more or less here.
Last raise 17.3 yr ago; this sector typically re-raises about every 13 months.
Latest round stepped up 4.0× from the prior — scaling.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Fair
Modeled value is 0.80× the median modeled value of Seed Other Technology companies in 2007–2009 (266 peers) — value vs value, same stage and era.
Within the normal band (80% of peer median) for its niche.
Dormant
Last raise 17.3 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Issuer-vehicle patternmedium confidence
Anti-Microbial Solutions, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
17.3 yr record
Peak capital year was 2009 with $5.5M across 6 filings.
Market position
ahead of 57% of Other Technology peers
Capital scale is ahead of 57% of Other Technology peers; modeled value is above 59% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
Legal name looks like an issuer vehicle rather than a product company.
No clearly named CEO/founder/principal role in the public records surfaced here.
No verified homepage on the profile yet.
Capital program peaked in 2009: $5.5M across 6 filings.
Largest single filing was $1.6M on 2009-03-24.
Filing rows sum to $5.5M, while canonical raised total is $4.5M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
Read this less like a startup funding journey and more like a capital-raising program.
Stage-based valuation and peer labels have lower applicability for this pattern.
The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Canonical filtering should be tightened before using row-level totals for diligence.
Leadership
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Where it sits in Other Technology
Anti-Microbial Solutions, LLC is one of 21302 Other Technology companies tracked from BEDFORD. By capital raised it ranks mid-pack (ahead of 57% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
US
Jurisdiction
Amount raised vs valuation, by round
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
Amount raised · realModeled valuation · estCumulative funded · real
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Financing ladder & sequence gaps
Seed$1.6M · 2009
Bridge · Seed-stage$1.0M · 2009smaller follow-on
Bridge · Seed-stage$925K · 2009smaller follow-on
Bridge · Seed-stage$725K · 2009smaller follow-on
Bridge · Seed-stage$250K · 2009smaller follow-on
Bridge · Seed-stage$1.0M · 2009smaller follow-on
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Modeled valuation trajectory
$54.5M
Base estimate est.
$1.4M
Conservative case
$427.7M
Upside case
$8.0M
Modeled post-money
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
39%
Survival probability
18% low · 61% high
1.61×/yr
Annual markup
2.11×/yr upside case
6.0 yr
Elapsed time used
17.3 yr actual, capped for stale marks
technology
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
—
Capital velocity
17.3 yr
On record since
2009
First round
6
Rounds on file
How it compares to the market
Benchmarked against 21302 companies in Other Technology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Total raised — vs sector median (real $, all stages)▲ 1.4× above median
This company$4.5M
Sector median$3.2M
Latest round — vs other Seed rounds in sector (real $, this stage)▼ 0.6× of median
This company$1.0M
Sector median$1.8M
Modeled value — vs sector median (estimate, all stages)▲ 1.5× above median
This company$54.5M
Sector median$37.3M
Raised more than 57% of sector peers (real $). Modeled value above 59% of peers (estimate).
Niche peers — same stage & era
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled valueest. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #162 of 266.
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
Stage
Amount · real
Announced
Post-money · est
Value · est
Conf.
Seed
$1.6M
2009-03-24
$8.0M
$54.5M
90%
Pre-Seed
$1.0M
2009-03-24
$5.6M
$42.4M
90%
Pre-Seed
$925K
2009-03-24
$5.1M
$39.2M
90%
Pre-Seed
$725K
2009-03-24
$4.0M
$30.7M
90%
Pre-Seed
$250K
2009-03-24
$1.4M
$10.6M
90%
Pre-Seed
$1.0M
2009-03-24
$5.6M
$42.4M
90%
What happened at each round
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Seed$1.6M2009-03-24
First recorded raise — entered as Seed.
Pre-Seed$1.0M2009-03-24
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 1.6× smaller than the prior — bridge or down round.
Pre-Seed$925K2009-03-24
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round roughly the size of the prior one.
Pre-Seed$725K2009-03-24
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round roughly the size of the prior one.
Pre-Seed$250K2009-03-24
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 2.9× smaller than the prior — bridge or down round.
Pre-Seed$1.0M2009-03-24
Filed alongside the prior round (same month) — likely a tranche or amendment.
Round 4.0× larger than the prior — scaling up.
Intelligence
—
Modeled next raise
$3.0M
Modeled next size est.range $2.0M–$4.8M
4.0×
Last step-up
—
Capital velocity
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Key people & operators
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
Anti-Microbial Solutions, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
United States
Country of record
US
Jurisdiction
1477256
SEC CIK
Similar companies
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
How much funding has Anti-Microbial Solutions, LLC raised?
Anti-Microbial Solutions, LLC has raised approximately $4.5M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Anti-Microbial Solutions, LLC's estimated valuation?
Provath's modeled valuation for Anti-Microbial Solutions, LLC is approximately $54.5M (modeled range $1.4M–$427.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Anti-Microbial Solutions, LLC at?
Anti-Microbial Solutions, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Tue Mar 24.
What does Anti-Microbial Solutions, LLC do and where is it based?
Anti-Microbial Solutions, LLC operates in the Other Technology sector, based in BEDFORD.
Explore related
See where Anti-Microbial Solutions, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Anti-Microbial Solutions, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.